Shareholders Equity: The sum of preferred and common equity items.
LENZ Therapeutics, Inc. (LENZ) had Shareholders Equity of $183.58M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-124.65M |
|
-- |
|
-- |
|
$135.19M |
|
$-135.19M |
|
$10.54M |
|
$-124.65M |
|
$-124.58M |
|
$-124.65M |
|
$-124.65M |
|
$-124.65M |
|
$-124.58M |
|
$-135.19M |
|
$-131.24M |
|
8.15M |
|
8.15M |
|
$-15.33 |
|
$-15.33 |
|
| Balance Sheet Financials | |
$188.02M |
|
-- |
|
$0.43M |
|
$188.46M |
|
$4.80M |
|
-- |
|
$0.08M |
|
$4.87M |
|
$183.58M |
|
$183.58M |
|
|
Shareholders Equity |
$183.58M |
8.29M |
|
| Cash Flow Statement Financials | |
$-90.01M |
|
$226.35M |
|
$0.19M |
|
$49.45M |
|
$185.97M |
|
$136.53M |
|
$10.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
39.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-98.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-67.90% |
|
-67.90% |
|
-66.14% |
|
-67.90% |
|
$22.15 |
|
$-12.15 |
|
$-11.05 |
|